Thank you for correcting the text in this article. Your corrections improve Papers Past searches for everyone. See the latest corrections.

This article contains searchable text which was automatically generated and may contain errors. Join the community and correct any errors you spot to help us improve Papers Past.

Article image
Article image
Article image
Article image

Foundation, 264 are known to have died, of whom S9 were men and 175 women. Among the patients with carcinoma, there were 239 deaths, and among the patient's with sarcoma there were 25 deaths. The mortality of the entire group of patients was 63.6 per cent, in the period from June, 1930, to 4th July, 1931. Fifty per cent, of the patients'died in the eight months from June to January.

As to the effects of the treatment, Dr. Harris says: "Malignant tumours were observed to increase ia size, and new extensions and uietastases to occur in many patients during the time they were receiving the extract, injections. In a few cases the great extent and rapidity of growtli of the tumours suggested that the extract might have stimulated the tumours to increased activity. ;xo tumour of any patient in this series was observed to disappear either spontaneously or as a result of the subcutaneous injections of suprarenal cortex substance. '*

Permanent link to this item

https://paperspast.natlib.govt.nz/newspapers/EP19320105.2.46

Bibliographic details

Evening Post, Volume CXIII, Issue 3, 5 January 1932, Page 6

Word Count
159

Untitled Evening Post, Volume CXIII, Issue 3, 5 January 1932, Page 6

Untitled Evening Post, Volume CXIII, Issue 3, 5 January 1932, Page 6

Help

Log in or create a Papers Past website account

Use your Papers Past website account to correct newspaper text.

By creating and using this account you agree to our terms of use.

Log in with RealMe®

If you’ve used a RealMe login somewhere else, you can use it here too. If you don’t already have a username and password, just click Log in and you can choose to create one.


Log in again to continue your work

Your session has expired.

Log in again with RealMe®


Alert